In addition, CREKA-labeled exosomes loaded with PTEN mRNA showed 1.5-fold higher accumulation in orthotopically implanted U87 glioma in C57BL/6 mice and increased survival with a median survival of 45 days, compared with 31 days for non-engineered exosomes [34]. The gene discussed is PTEN; the disease is central nervous system cancer.